59
Views
2
CrossRef citations to date
0
Altmetric
Miscellaneous

GlaxoSmithKline’s CCR3 chemokine receptor antagonists

Pages 577-582 | Published online: 22 Apr 2005
 

Abstract

A series of nine closely related applications claiming various acyl and urea derivatives of 2-aminomethyl-4-benzylmorpholine are considered. These claim CCR3 chemokine receptor antagonists, some of which have affinities in the 10 – 100 pM range. They are claimed to be useful in the treatment of asthma, allergic rhinitis and other inflammatory diseases. One of the applications (WO03082292) claims inter alia 766994, a clinical development candidate, currently in Phase II studies for the treatment of asthma and allergic rhinitis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.